- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07733973
Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer (CCC-Cancer)
Evaluating the Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer
The goal of this clinical trial is to evaluate the communication and care coordinator (CCC) model in a national cancer institute and assess the utility of the model in facilitating serious illness communication (SIC) and care for patients with cancer.
The study aims are:
- To assess the effectiveness of the CCC model in improving patient outcomes.
- To assess the effectiveness of the CCC model in increasing rates of SIC and advance care planning (ACP) record documentation.
- To assess the acceptability of the CCC model to patients and clinicians.
- To evaluate the feasibility of implementing a CCC model in oncology care.
Researchers will compare results from the CCC intervention arm and usual care arm, to see if the CCC model can help improve patient outcomes and facilitate SIC between patients and clinicians.
Patient participants will:
- Follow the assignment of their clinician, who will be assigned randomly to either the usual care group or the intervention group.
- Be assigned a CCC and receive 6 CCC sessions over the course of 3 months (if assigned to CCC intervention arm).
- Complete 3 study assessment visits at baseline, Week 6, and 3 months
- Be invited to a one-time interview to share their study experience (optional, if selected and if in CCC intervention arm).
Visão geral do estudo
Descrição detalhada
Timely SIC may facilitate earlier preferred plan of care documentation and improve patients' sense of peacefulness, hopefulness, and connectedness with their clinicians. The primary goal of the study is to evaluate the CCC model in a national cancer institute and assess the utility of the model in facilitating SIC and care for patients with cancer through a stepped wedge cluster randomized trial. This approach delivers crucial, empirical insights into how SIC can be efficiently and effectively delivered and potentially allow larger scale implementation and dissemination of the CCC model in Singapore, as an effective model for delivering patient support and facilitating patient-clinician communication in patients with advanced cancer.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Shirlyn NEO Hui Shan, MD, PhD
- Número de telefone: 63065838
- E-mail: shirlyn.neo.h.s@singhealth.com.sg
Estude backup de contato
- Nome: Benton PT TAM, MSc
Locais de estudo
-
-
-
Singapore, Cingapura, 168583
- Recrutamento
- National Cancer Center, Singapore
-
Contato:
- Shirlyn NEO Hui Shan, MD, PhD
-
Contato:
- Número de telefone: 63065838
- E-mail: shirlyn.neo.h.s@singhealth.com.sg
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Patient Participants
- Aged 21 and above
- Diagnosed with (a) advanced cancer (stage 3 or 4) or (b) non-advanced cancer, but at high risk of recurrence
- Able to speak English or Chinese, irrespective of race
Clinicians
- Oncologists who are at least of designation of associate consultant and above in NCCS
Exclusion Criteria:
Patient Participants
- Disoriented and thus not able to sign informed consent
- Diagnosed with untreated hearing or visual loss or psychiatric illness
- Active suicidal ideation
Clinicians
- Overseas/not practising in Singapore for a significant amount of time
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: CCC Intervention Arm
Each participant will be assigned a CCC and receive 6 CCC sessions over the course of 3 months. |
CCC sessions will be on exploring participant's illness journey thus far, their concerns, values and priorities. |
|
Sem intervenção: Usual Care Arm
Each participant will continue to be followed by the oncologist and receive usual care but will not receive CCC intervention. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Communication Quality
Prazo: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
Feeling Heard and Understood Survey (FHU) is a validated 4-item scale that has been used in palliative care to measure effectiveness of the SIC conversations and the value of the therapeutic relationship between the care team and the patient. The lowest possible score is 0 and the highest possible score is 16, with a higher score indicating that the care team listens well, respects patient's needs, and provides clear communication. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Quality of Life per FACT-G7
Prazo: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
Functional Assessment of Cancer Therapy-General-7 Item version (FACT-G7) is a 7-item questionnaire designed to quickly and effectively capture the most relevant issues to cancer. FACT-G7 scores could potentially range from 0-28, with a higher score indicating a better quality of life. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Health Utility
Prazo: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
EuroQOL Group 5-Dimension (EQ-5D-5L) contains a 5-item descriptive system measuring 5 dimensions: mobility, self-care, usual activities, pain/ discomfort, anxiety/ depression; a visual analogue scale (VAS) measuring overall health status. EQ-5D Index Value (Utility Score) ranges from 0 to 1.0 with higher value indicating better health-related quality of life. The VAS ranges from 0 to 100, with higher scores reflecting better self-rated health. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Spiritual Well-Being
Prazo: Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being 12 Item Scale (FACIT-Sp-12) is a validated 12-item survey that is commonly used in the palliative care setting. It has 3 subscales (meaning, peace and faith). Scores in each subscale can potentially range from 0-16 and the total scores can range from 0-48. A higher score indicates greater spiritual well-being, better ability to find purpose in life and drawing comfort from spiritual resources. |
Baseline, Week 6 after Baseline, and 3 months Post Enrolment.
|
|
Healthcare Utilization - Rate of Unplanned Acute Hospital Utilization
Prazo: From Study Enrolment to 3 months Post Enrolment.
|
The rate of unplanned acute hospital utilization through the emergency department during the study will be collected. |
From Study Enrolment to 3 months Post Enrolment.
|
|
Healthcare utilization - Length of hospital stay
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the length of stay in hospital (bed days) will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Hospital Bill
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on hospital bill size will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Type of oncological treatment
Prazo: From 3 months prior to study enrolment until 3 months after study enrolment.
|
Data on the type of oncological treatment used will be collected. |
From 3 months prior to study enrolment until 3 months after study enrolment.
|
|
Healthcare utilization - Chemotherapy usage (line)
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the line of chemotherapy (first, second or third or subsequent (fourth and onwards)) will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Intensive care unit visit
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the number of intensive care unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Length of intensive care unit visit
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the length of intensive care unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - High dependency unit visit
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the number of high dependency unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Length of high dependency unit visit
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the length of high dependency unit visits will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
|
Healthcare utilization - Location of death
Prazo: From Study Enrolment until Date of Death, up to 3 years.
|
Data on the location of death will be collected. |
From Study Enrolment until Date of Death, up to 3 years.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Acceptability - Satisfaction
Prazo: 3 months Post Enrolment.
|
Client satisfaction survey is a 4-item, 4-point scale survey in which patients provide ratings on their satisfaction with the intervention, and their views on its relevance, timeliness, and impact. It has been validated in research studies in the outpatient setting around mental health support. Score can range from 4-16, with a higher score indicating greater client satisfaction. |
3 months Post Enrolment.
|
|
Feasibility - Approach-to-Enrolment Rates
Prazo: From Commencement of Study Recruitment till the End of Recruitment, up to 24 months.
|
Approach-to-enrolment rates - where feasibility is defined that at least 60% of those patients approached could be enrolled into the study. |
From Commencement of Study Recruitment till the End of Recruitment, up to 24 months.
|
|
Feasibility - Patient Retention Rate
Prazo: Baseline through Study Completion, estimated as up to 3 years.
|
Patient retention rate - where feasibility is defined that at least 80% of enrolled patients will be able to participate in the study for the planned study duration (3 months). |
Baseline through Study Completion, estimated as up to 3 years.
|
|
Effectiveness - SIC and ACP documentation
Prazo: From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
The number of SIC and ACP documentation per clinician per enrolled patient during the study duration will be tracked during the intervention period(s) and during the control period(s). Clinical notes will also be read to evaluate if there was relevant documentation by clinician on SIC related issues. |
From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
|
Effectiveness - Time spent
Prazo: From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
Time spent by CCC in this model and estimated time spent by clinicians on SICs will be collected. |
From Commencement of Study Enrollment through Study Completion, estimated as up to 3 years
|
|
Acceptability - Clinician experience
Prazo: At end of intervention period (28th month).
|
Clinicians will be surveyed using a modified version of the Clinician Experience Survey (CES). The original CES was developed by Ariadne Labs for the purposes of assessing clinicians perceived feasibility and barriers in engaging patients in SIC. The researchers will modify the CES to form a 4-item scale (score range 4-16), with a higher score indicating greater clinicians' satisfaction with the CCC intervention. |
At end of intervention period (28th month).
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Shirlyn NEO Hui Shan, MD, PhD, National Cancer Centre, Singapore
Publicações e links úteis
Publicações Gerais
- Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42.
- Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
- Sudore RL, Fried TR. Redefining the "planning" in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010 Aug 17;153(4):256-61. doi: 10.7326/0003-4819-153-4-201008170-00008.
- Bernacki RE, Block SD; American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014 Dec;174(12):1994-2003. doi: 10.1001/jamainternmed.2014.5271.
- Nikbakhsh N, Moudi S, Abbasian S, Khafri S. Prevalence of depression and anxiety among cancer patients. Caspian J Intern Med. 2014 Summer;5(3):167-70.
- Kumar P, Wixon-Genack J, Kavanagh J, Sanders JJ, Paladino J, O'Connor NR. Serious Illness Conversations With Outpatient Oncology Clinicians: Understanding the Patient Experience. JCO Oncol Pract. 2020 Dec;16(12):e1507-e1515. doi: 10.1200/JOP.19.00765. Epub 2020 Aug 4.
- Geerse OP, Lamas DJ, Sanders JJ, Paladino J, Kavanagh J, Henrich NJ, Berendsen AJ, Hiltermann TJN, Fromme EK, Bernacki RE, Block SD. A Qualitative Study of Serious Illness Conversations in Patients with Advanced Cancer. J Palliat Med. 2019 Jul;22(7):773-781. doi: 10.1089/jpm.2018.0487. Epub 2019 Feb 6.
- Paladino J, Koritsanszky L, Nisotel L, Neville BA, Miller K, Sanders J, Benjamin E, Fromme E, Block S, Bernacki R. Patient and clinician experience of a serious illness conversation guide in oncology: A descriptive analysis. Cancer Med. 2020 Jul;9(13):4550-4560. doi: 10.1002/cam4.3102. Epub 2020 May 4.
- Baxter R, Fromme EK, Sandgren A. Patient Identification for Serious Illness Conversations: A Scoping Review. Int J Environ Res Public Health. 2022 Mar 31;19(7):4162. doi: 10.3390/ijerph19074162.
- Agency for integrated care. Advance care planning. Accessed via: aic.sg/Care-Services/Advance-Care-Planning-ACP. Last accessed on February 6th 2026.
- Epstein AS, Riley M, Nelson JE, Bernal C, Martin S, Xiao H. Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes. Cancer. 2022 Sep 15;128(18):3400-3407. doi: 10.1002/cncr.34400. Epub 2022 Jul 22.
- Karim S, Levine O, Simon J. The Serious Illness Care Program in Oncology: Evidence, Real-World Implementation and Ongoing Barriers. Curr Oncol. 2022 Mar 2;29(3):1527-1536. doi: 10.3390/curroncol29030128.
- Malhotra C, Chaudhry I. Barriers to advance care planning among patients with advanced serious illnesses: A national survey of health-care professionals in Singapore. Palliat Support Care. 2024 Oct;22(5):978-985. doi: 10.1017/S1478951523000214.
- Ahluwalia SC, Levin JR, Lorenz KA, Gordon HS. Missed opportunities for advance care planning communication during outpatient clinic visits. J Gen Intern Med. 2012 Apr;27(4):445-51. doi: 10.1007/s11606-011-1917-0. Epub 2011 Oct 25.
- Shilling DM, Manz CR, Strand JJ, Patel MI. Let Us Have the Conversation: Serious Illness Communication in Oncology: Definitions, Barriers, and Successful Approaches. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e431352. doi: 10.1200/EDBK_431352.
- Nagelschmidt K, Leppin N, Seifart C, Rief W, von Blanckenburg P. Systematic mixed-method review of barriers to end-of-life communication in the family context. BMJ Support Palliat Care. 2021 Sep;11(3):253-263. doi: 10.1136/bmjspcare-2020-002219. Epub 2020 Aug 27.
- Hanley S, Cotner CE, Fenton A, Wright AA, Manz CR. Barriers to Serious Illness Conversations Among Patients with Advanced Cancer: A Qualitative Study. J Pain Symptom Manage. 2025 Feb;69(2):183-189.e4. doi: 10.1016/j.jpainsymman.2024.10.034. Epub 2024 Nov 7.
- Martina D, Geerse OP, Lin CP, Kristanti MS, Bramer WM, Mori M, Korfage IJ, van der Heide A, Rietjens JA, van der Rijt CC. Asian patients' perspectives on advance care planning: A mixed-method systematic review and conceptual framework. Palliat Med. 2021 Dec;35(10):1776-1792. doi: 10.1177/02692163211042530. Epub 2021 Sep 6.
- Patel MI, Periyakoil VS, Blayney DW, Moore D, Nevedal A, Asch S, Milstein A, Coker TR. Redesigning Cancer Care Delivery: Views From Patients and Caregivers. J Oncol Pract. 2017 Apr;13(4):e291-e302. doi: 10.1200/JOP.2016.017327. Epub 2017 Feb 7.
- Patel MI, Kapphahn K, Dewland M, Aguilar V, Sanchez B, Sisay E, Murillo A, Smith K, Park DJ. Effect of a Community Health Worker Intervention on Acute Care Use, Advance Care Planning, and Patient-Reported Outcomes Among Adults With Advanced Stages of Cancer: A Randomized Clinical Trial. JAMA Oncol. 2022 Aug 1;8(8):1139-1148. doi: 10.1001/jamaoncol.2022.1997.
- Patel MI, Ramirez D, Agajanian R, Agajanian H, Coker T. Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer. JAMA Netw Open. 2020 Mar 2;3(3):e201023. doi: 10.1001/jamanetworkopen.2020.1023.
- Lee ASY, Tang SN, Phua GLG, Yee AC, Neo SH. Adaptation of the Serious Illness Conversation Guide to Singapore's Multicultural Setting for Patients With Heart Failure, Renal Failure, or Cancer. Palliat Med Rep. 2024 Mar 26;5(1):122-126. doi: 10.1089/pmr.2023.0086. eCollection 2024.
- Ramakrishnan C, Lee ASY, Malhotra C, Phua GLG, Yee A, Neo SH. Adaptation of the serious illness conversation guide to a multicultural context in Singapore: a qualitative study. BMJ Open. 2025 Oct 23;15(10):e098264. doi: 10.1136/bmjopen-2024-098264.
- Ng A, Phua GL, Neo HS. Iterative adaptation and acceptability testing of the serious illness conversation guide for use with mandarin-speaking patients. Pal Med Rep. 2025 Nov;11(1):564-573.
- Ng A, Sivasamy V, Neo SHS. Cultural adaptation of the serious illness conversation guide for caregivers of persons with dementia in Singapore. BMC Geriatr. 2025 Dec 30;25(1):1075. doi: 10.1186/s12877-025-06761-4.
- Ng A, Yeo SM, Neo SH. Patient Readiness for Serious Illness Conversations: Identifying Psycho-Emotional Barriers Through a Phenomenological Lens. Psychooncology. 2025 Nov;34(11):e70317. doi: 10.1002/pon.70317.
- Gov.sg. Scribe. Accessed via: https://reports.open.gov.sg/scribe/overview Last accessed on February 9th, 2026.
- Chan HY, Leung DY, Lam PT, Ko PP, Lam RW, Chan KS. Effect of motivational interviewing to promote advance care planning among palliative care patients in ambulatory care setting: a randomized controlled trial. BMC Palliat Care. 2025 Jan 31;24(1):31. doi: 10.1186/s12904-025-01667-9.
- Edelen MO, Rodriguez A, Huang W, Gramling R, Ahluwalia SC. A novel Scale to Assess Palliative Care Patients' Experience of Feeling Heard and Understood. J Pain Symptom Manage. 2022 May;63(5):689-697.e1. doi: 10.1016/j.jpainsymman.2022.01.002. Epub 2022 Jan 10.
- Bandini JI, Schulson LB, Messan Setodji C, Williams J, Ast K, Ahluwalia SC. "Palliative Care Is the Only Medical Field That I Feel Like I'm Treated As a Person, Not As a Black Person": A Mixed-Methods Study of Minoritized Patient Experiences with Palliative Care. J Palliat Med. 2023 Feb;26(2):220-227. doi: 10.1089/jpm.2022.0237. Epub 2022 Aug 16.
- FACIT.org. Functional assessment of cancer therapy-general-7 item version. Accessed via: facit.org/measures/fact-g7. Last accessed on February 8th, 2026.
- EUROQOL. EQ-5D-5L. Accessed via: euroqol.org/information-and-support/euroqol-instruments-eq-5d-5l/. Last accessed on February 8th, 2026.
- FACIT.org. Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being 12 Item Scale (FACIT-Sp-12). Last accessed via: https://www.facit.org/measures/facit-sp-12 Accessed on February 8th, 2026.
- CSQ scales. CSQ-4. Accessed via: https://csqscales.com/product/csq-04/ Last accessed on February 8th, 2026.
- Pedersen H, Skliarova T, Attkisson CC, Lara-Cabrera ML, Havnen A. Measuring patient satisfaction with four items: validity of the client satisfaction questionnaire 4 in an outpatient population. BMC Psychiatry. 2023 Nov 7;23(1):808. doi: 10.1186/s12888-023-05310-w.
- Ariadne Labs. ARIA. Accessed via: https://www.ariadnelabs.org/aria/ Last accessed February 2nd, 2026.
- Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101. doi.org/10.1191/1478088706qp063oa
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026-1239
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .